Chuanning Bio
Overview
Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally. It offers antibiotic intermediates comprising erythromycin thiofluorate; cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA; penicillin intermediates, such as 6-aminopenicillanic acid (6-A
Employees3126
Market Cap$19.0B
Revenue$4.4B
Listed OnShenzhen Stock Exchange
Ticker301301
CEOMr. Xuheng Deng
HeadquartersYining